Association of the CYP2B6 c.516G>T Polymorphism with High Blood Propofol Concentrations in Women from Northern Greece

被引:27
|
作者
Mastrogianni, Orthodoxia [1 ]
Gbandi, Emma [2 ]
Orphanidis, Amvrosios [1 ]
Raikos, Nikolaos [1 ]
Goutziomitrou, Evangelia [3 ]
Kolibianakis, Efstratios M. [3 ]
Tarlatzis, Basil C. [3 ]
Goulas, Antonis [2 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Med, Dept Forens Med & Toxicol, Thessaloniki 54124, Greece
[2] Aristotle Univ Thessaloniki, Sch Med, Dept Pharmacol, Thessaloniki 54124, Greece
[3] Aristotle Univ Thessaloniki, Sch Med, Papageorgiou Gen Hosp, Dept Obstet & Gynecol 1,Unit Human Reprod, Thessaloniki 54124, Greece
关键词
blood propofol; GC/MS; CYP2B6; gene polymorphism; HUMAN LIVER; UGT1A9; PHARMACOKINETICS; GLUCURONIDATION; METABOLITES; EXPRESSION; IMPACT; GENE;
D O I
10.2133/dmpk.DMPK-13-NT-092
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 2B6 (CYP2B6) is responsible for the initial biotransformation of profol, an extensively metabolized intravenous anesthetic. In this study we examined the effect of the apparently functional CYP2B6 c.516G>T polymorphism on the distribution of propofol concentrations, quantified by GC/MS analysis following a single bolus dose, in the blood of 44 Greek women undergoing oocyte retrieval. Univariate analysis using age, height, weight and smoking status as covariates, as well as the Mann-Whitney non-parametric test, revealed a strong trend of association of the T allele with high propofol concentrations determined in whole blood, shortly after a single bolus dose. Propofol concentrations which were higher than one standard deviation of the mean were almost invariably associated with carriage of the T allele.
引用
收藏
页码:215 / 218
页数:4
相关论文
共 50 条
  • [1] Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability
    Mourao, Artemisia L.
    de Abreu, Fabiana G.
    Fiegenbaum, Marilu
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (05) : 511 - 515
  • [2] Aberrant splicing caused by single nucleotide polymorphism c.516G> T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver
    Hofmann, Marco H.
    Blievernicht, Julia K.
    Klein, Kathrin
    Saussele, Tanja
    Schaeffeler, Elke
    Schwab, Matthias
    Zanger, Ulrich M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (01): : 284 - 292
  • [3] Differential Impact of Nevirapine on Artemether-Lumefantrine Pharmacokinetics in Individuals Stratified by CYP2B6 c.516G>T Genotypes
    Abdullahi, Sa'ad T.
    Soyinka, Julius O.
    Olagunju, Adeniyi
    Bolarinwa, Rahman A.
    Olarewaju, Olusola J.
    Bakare-Odunola, Moji T.
    Winterberg, Markus
    Tarning, Joel
    Owen, Andrew
    Khoo, Saye
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [4] Comparison of the TaqMan and LightCycler systems in evaluation of CYP2B6 516G>T polymorphism
    Chantarangsu, Soranun
    Cressey, Tim
    Mahasirimongkol, Surakameth
    Tawon, Yardpiroon
    Ngo-Giang-Huong, Nicole
    Jourdain, Gonzague
    Lallemant, Marc
    Chantratita, Wasun
    MOLECULAR AND CELLULAR PROBES, 2007, 21 (5-6) : 408 - 411
  • [5] ASSOCIATION OF CYP2B6 G516T POLYMORPHISM WITH THE SUSCEPTIBILITY OF de novo ACUTE MYELOGENOUS LEUKEMIA
    Daraki, A.
    Zachaki, S.
    Koromila, T.
    Karakosta, M.
    Pantelias, G.
    Aleporou, V.
    Sambani, C.
    Kollia, P.
    Manola, K.
    HAEMATOLOGICA, 2012, 97 : 262 - 262
  • [6] Plasma efavirenz concentrations and the association with CYP2B6-516G>T polymorphism in HIV-infected Thai children
    Puthanakit, Thanyawee
    Tanpaiboon, Pranoot
    Aurpibul, Linda
    Cressey, Tim R.
    Sirisanthana, Virat
    ANTIVIRAL THERAPY, 2009, 14 (03) : 315 - 320
  • [7] Distribution of CYP2B6 516G/T pharmacogenetically important polymorphism in the Ukrainian population
    Filiptsova, Olga
    Kobets, Marina
    Kobets, Julia
    Naboka, Olga
    Koiro, Olga
    Ochkur, Alexandr
    Galiy, Larisa
    SAUDI PHARMACEUTICAL JOURNAL, 2018, 26 (05) : 651 - 655
  • [8] IMPLICATIONS OF SCREENING FOR CYP2B6 516G>T SNP ON HIV/AIDS PATIENTS
    Swart, M.
    Dandara, C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 163 - 164
  • [9] The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes Lessons from Botswana
    Maseng, Monkgomotsi J.
    Tawe, Leabaneng
    Thami, Prisca K.
    Moyo, Sikhulile
    Kasvosve, Ishmael
    Novitsky, Vladimir
    Essex, Max
    Russo, Gianluca
    Gaseitsiwe, Simani
    Paganotti, Giacomo M.
    MEDICINE, 2022, 101 (17) : E29066
  • [10] Occurrence of CYP2B6 516G>T polymorphism in patients with ARV-associated hepatotoxicity
    Singh, HariOm
    Lata, Sonam
    Dhole, T. N.
    Gangakhedkar, Raman R.
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (04):